Search Results 441-450 of 7925 for driving with dementia
Mayo Clinic has created a predictive model for the diagnosis of Alzheimer's disease in African Americans. The model incorporates plasma mRNA measures.
The primary study hypothesis is that at least one MK-8931 dose is superior to placebo with respect to the change from baseline in the Clinical Dementia ...
... dementia, according to a new study published in the April 8, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.
... Alzheimer's reducing amyloid accumulation in the brain as ... During the clinical trial, patients who had mild cognitive impairment or very mild dementia ...
That number is expected to triple by 2050 if effective treatments cannot be found. Alzheimer's has no cure and the five medications the U.S. Food and Drug ...
Among those individuals, 1,085 were healthy, 480 had mild cognitive impairment, 215 had Alzheimer's disease, 86 had Lewy body dementia and 45 had frontotemporal ...
Mayo Clinic Center for Clinical and Translational Science (CCaTS): Profile of Christiana (Noelle) N. Driver, a student in the M.D.-M.S. Program.
– More than 5 million people in the U.S. have Alzheimer's disease, a progressive disease that destroys memory and other important mental functions.
help ward off symptoms of Alzheimer's disease. Prashanthi Vemuri, Ph.D. “May delay the onset of dementia by about three to eight years, which is a very long ...
When the SPRINT study intervention was stopped in September of 2015, important data on long term rate of Alzheimer's, change in cognition, and impact on the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.